Euclid Ventures

Euclid makes high-conviction, pre-product venture investments exclusively in vertical AI — industry-specific software powered by artificial intelligence. The firm enters before companies have built a product, hired a team, or in some cases even incorporated, providing capital and operational support from what it calls "Day Zero." Its portfolio spans sectors such as youth sports, elective health, dental practice management, and emergency services.

Euclid blends elements of both. It writes early-stage checks like a seed fund but layers on a company-building platform that includes research, an executive network, and pre-incorporation support. Its public materials emphasize partnership from inception and a structured "Learn, Connect, Partner" framework, positioning it closer to a thesis-driven studio than a passive seed investor — though it does not formally label itself a studio.

Euclid does not publicly name its investment committee, general partners, or operating team on its website. The firm's public identity is built around its vertical AI thesis and portfolio rather than individual principals. No named decision-makers are verifiable from its own digital presence as of 2026.

The firm focuses on the earliest possible stage: pre-product, pre-traction, pre-team, and often pre-incorporation. It categorizes its activity as seed and start-up venture capital. There is no indication that Euclid participates in later-stage rounds or growth equity, preserving its model around initial capital deployment and company formation.

No. Euclid does not disclose assets under management, fund size, or total capital deployed on its website or through any other public channel. Its financial scale remains entirely private.

Euclid's sourcing appears to flow through its content engine — a library of essays on vertical AI themes — and its curated executive network, which it invites operators to join. The firm publishes research with titles like "The Fundability Trap" and "Voice-First Playbooks in Vertical AI," acting as both thought leader and top-of-funnel for founder relationships. No external data confirms deal flow sourced through traditional agent or GP relationships.

Euclid's thesis is conspicuously narrow: it invests only in vertical AI and does not reference horizontal SaaS, infrastructure AI, consumer technology, or life sciences. The firm's research titles and portfolio confirm a deliberate avoidance of companies outside industry-specific AI applications, though it does not publish a formal exclusion list.